Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
The RSUs vest 25% on each annual anniversary of the vesting commencement date. The awards are subject to the terms and conditions of the 2023 Inducement Incentive Plan and the terms and conditions of the stock option agreement or RSU agreement, as applicable, covering the grant, including requirements to remain continuously employed on each vesting date.
About Evolus, Inc.
Evolus (NASDAQ: EOLS) is a global performance beauty company redefining the aesthetic injectable market for the next generation of beauty consumers through its unique, customer-centric business model and innovative digital platform. Our mission is to become a global leader in aesthetics anchored by our flagship products: Jeuveau® (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics, and Evolysse™, a collection of unique injectable hyaluronic acid (HA) gels. Visit us at www.evolus.com, and follow us on LinkedIn, X, Instagram or Facebook.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
19 minutes ago
- Globe and Mail
2 Stocks to Buy From the Challenging Semiconductor Industry
The Zacks Electronics - Semiconductors industry is suffering from macroeconomic challenges, end-market volatility, broad-based inventory correction and growing geopolitical tensions. Tariffs on trade partners, including China, are expected to hurt the industry's prospects. However, industry players are benefiting from the growing proliferation of AI, Generative AI (Gen AI), IoT, Machine Learning (ML) and industrial revolution 4.0 (which focuses on interconnectivity and automation). These have turned out to be boons for industry players like Broadcom AVGO and Applied Materials AMAT. Increasing demand for AI-supportive chips from hyperscalers is a major growth driver. The growing demand for high-volume consumer electronic devices, including digital media players, smartphones, tablets, efficient packaging, machine vision solutions and robotics, should continue to drive the industry's growth. Industry Description The Zacks Electronics – Semiconductors industry comprises companies that provide a wide range of semiconductor technologies. Their offerings include packaging and test services, wafer cleaning, factory automation, face detection and image-recognition capabilities to develop smart and connected products. The industry participants primarily cater to end markets that include consumer electronics, communications, computing, industrial and automotive. The companies are increasing their spending on research and development to stay afloat in an era of technological advancements and changing industry standards. The industry is experiencing solid demand for advanced electronic equipment, which is helping its participants increase their investments in cost-effective process technologies. What's Shaping the Future of the Electronics - Semiconductors Industry? AI Demand Driving Prospects: Industry participants are benefiting from growing demand for advanced manufacturing processes and energy-efficient computing power, both of which are needed to develop AI-supportive chips. AI is gaining popularity thanks to multimodal learning and growing context awareness. The emergence of Gen AI and Agentic AI has further enhanced AI's capabilities, making it a key driver of efficiency, automation and innovation. Significant improvements in computing hardware (GPUs and TPUs) are allowing the development of more complex AI models. The growing number of high-speed data centers worldwide, which require ultra-fast Internet that 5G promises to deliver, is a tailwind. Increased connectivity and use of technology in consumer electronics through IoT, AI, robotics, AR/VR and others further set the momentum for 5G. Smart Devices Aiding Computing Demand: Smart devices need computing and learning capabilities to perform functions like face detection, image recognition and video analytics capabilities. These require high levels of processing power, speed and memory and low power consumption, as well as better graphics processors and solutions, which bode well for the industry. Graphic solutions help increase the speed of rendering images and improve image resolution and color definition. Prospects Around Advanced Packaging Robust: The increasing demand for miniaturization, greater functionality, lower power consumption, and improved thermal and electrical performance are driving the demand for semiconductor packaging and test technologies. The growing requirement for advanced packaging is gaining traction in the semiconductor industry, which is a key catalyst for industry participants. Complex Process Drives Demand: The requirement for faster, more powerful and energy-efficient semiconductors is expected to increase rapidly with the robust adoption of cloud computing, IoT and AI. Semiconductor manufacturers are primarily looking to maximize manufacturing yields at lower costs, making semiconductor manufacturing processes more complex and driving the demand for solutions offered by industry participants. The rapid adoption of IoT-supported factory automation solutions is another contributing factor. Zacks Industry Rank Indicates Dim Prospects The Zacks Electronics - Semiconductors industry is housed within the broader Zacks Computer and Technology sector. It currently carries a Zacks Industry Rank #182, which places it in the bottom 25% of more than 250 Zacks industries. The group's Zacks Industry Rank, which is the average of the Zacks Rank of all the member stocks, indicates bearish near-term prospects. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than two to one. The industry's positioning in the bottom 50% of the Zacks-ranked industries is a result of the negative earnings outlook for the constituent companies in aggregate. Looking at the aggregate earnings estimate revisions, it appears that analysts are optimistic about this group's earnings growth potential. Since April 30, 2025, the industry's earnings estimates for the current year have moved down 3.6%. Given the bearish prospects, there are only a few stocks that you can consider for your portfolio. However, before we present the stocks, let us look at the industry's recent stock-market performance and valuation picture. Industry Outperforms S&P 500 & Sector The Zacks Electronics - Semiconductors industry has outperformed the Zacks S&P 500 composite and surpassed the broader Zacks Computer and Technology sector in the past year. The industry has appreciated 51.5% over this period compared with the Zacks Computer and Technology sector's return of 29.1% and the S&P 500's appreciation of 20.3%. One-Year Price Performance Industry's Current Valuation On the basis of the forward 12-month price-to-earnings ratio, which is a commonly used multiple for valuing electronics semiconductor stocks, the industry is currently trading at 34.32X versus the S&P 500 and the sector's 22.69X and 28.15X, respectively. Over the past five years, the industry has traded as high as 34.32X and as low as 11.05X, with the median being 19.7X, as the charts below show. Forward 12-Month Price-to-Earnings (P/E) Ratio 2 Electronics Semiconductor Stocks to Buy Broadcom: This Zacks Rank #2 (Buy) company is benefiting from strong momentum fueled by growth in AI semiconductors and continued success with its VMware integration. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Strong demand for Broadcom's networking products and custom AI accelerators (XPUs) has been noteworthy. AVGO's AI segment benefits from custom accelerators and advanced networking technology that support large-scale AI deployments with improved performance and efficiency. Broadcom expects third-quarter fiscal 2025 AI revenues to jump 60% year over year to $5.1 billion. The acquisition of VMware has benefited Infrastructure software solutions. As of the fiscal second quarter, roughly 87% of Broadcom's largest 10,000 customers have adopted VMware Cloud Foundation. Broadcom stock has appreciated 31% year to date (YTD). The Zacks Consensus Estimate for AVGO's fiscal 2025 earnings has been steady at $6.63 per share over the past 60 days. Price & Consensus: AVGO Applied Materials: Another Zacks Rank #2 stock, AMAT is benefiting from strength in the Semiconductor Systems, owing to a rebound in the semiconductor industry, particularly in the foundry logic space. Solid momentum in the subscription and display businesses is a plus for Applied Materials. The company's strong position in IoT, Communications, Auto, Power and Sensors (ICAPS) has helped it gain market share. AMAT's diversified portfolio remains its key growth driver. Applied Materials has appreciated 16.2% YTD. The Zacks Consensus Estimate for AMAT's fiscal 2025 earnings has declined by a penny to $9.46 per share over the past 30 days. Price & Consensus: AMAT Zacks' Research Chief Names "Stock Most Likely to Double" Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest. This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%. Free: See Our Top Stock And 4 Runners Up Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Broadcom Inc. (AVGO): Free Stock Analysis Report Applied Materials, Inc. (AMAT): Free Stock Analysis Report
Globe and Mail
19 minutes ago
- Globe and Mail
When a Healthcare Giant Gets Sick: Elevance Health's 20% YTD Decline
Elevance Health, Inc. ELV has endured a bruising 2025 so far, sliding 20.3% year to date and lagging both its industry peers and the S&P 500 Index. Shares closed Friday at $293.99, hovering just above the lower edge of their 52-week range of $273.71–$567.26. For value hunters, the stock's current level may look like an attractive entry point into a leading health benefits player; after all, buying closer to the low than the high has its appeal, right? Based in Indianapolis, IN, Elevance carries a market capitalization of $66.2 billion. Its peers like UnitedHealth Group Incorporated UNH and Centene Corporation CNC have also stumbled this year, in some cases even more sharply. In fact, UnitedHealth's sheer weight in the health insurance space has dragged down the sector on multiple occasions, while Centene has also contributed to the selling pressure. Price Performance – ELV, UNH, CNC, Industry & S&P 500 What's Dragging Down ELV Stock? Several headwinds are hitting Elevance simultaneously. Medicaid membership has shrunk 15.1% in 2024 and another 4.1% in the first half of 2025, erasing members and the revenues they bring. Medicare Supplement and employer group risk-based memberships in the commercial business are also slipping. The situation is likely to remain choppy into 2026, especially with the GOP's recently passed tax-and-policy package, which slashes Medicaid funding and overhauls Affordable Care Act eligibility and enrollment rules. Meanwhile, medical costs are climbing as utilization grows, compressing margins. In the second quarter, the company's benefit expense ratio worsened 260 basis points year over year to 88.9%. Full-year benefit expense ratio is expected at approximately 90%, with the second half likely to witness steeper jumps. Investor sentiment soured further as management cut its full-year 2025 outlook. The company now expects adjusted EPS to be around $30, lower than the previously forecasted range of $34.15-$34.85, down from the 2024 reported figure of $33.04. Its peers, such as UnitedHealth and Centene, also lowered their expectations for the current year. Adding to the unease, President Donald Trump's sharp criticism of pharmacy benefit managers (PBMs) in his push to lower drug prices has put companies with PBM exposure — including Elevance, UnitedHealth and Cigna — under a regulatory and political cloud. Centene sidestepped potential trouble by exiting its PBM operations a few years ago, executing the move as part of its broader value-creation strategy. Analysts Turn Cold for ELV Over the past month, 2025 and 2026 earnings estimates have each seen double-digit downward revisions, 16 and 14 cuts, respectively, with no upgrades in sight. The current Zacks Consensus Estimate calls for 2025 EPS of $30.59, a 7.4% decline from the prior year, despite revenue projections implying a 12.4% gain. The company's earnings track record has been mixed, beating expectations twice in the past four quarters but missing twice as well, for an average surprise of negative 2.3%. Elevance Health, Inc. Price, Consensus and EPS Surprise Elevance Health, Inc. price-consensus-eps-surprise-chart | Elevance Health, Inc. Quote ELV's Valuation: Cheap, But for a Reason? At a forward 12-month P/E of 9.24X, Elevance Health trades well below both its five-year median of 13.44X and the industry average of 14.32X, a valuation gap that reflects investor caution. UnitedHealth and Centene, despite suffering steeper sell-offs, command higher multiples of 14.05X and 9.94X, respectively. Why the Long Game Still Works Despite the near-term turbulence, Elevance retains solid long-term growth levers. Product expansion, revenue diversification, rate hikes, and selective growth in commercial lines should help offset pressures. Premium increases and a sharper focus on optimizing the government business position the company to benefit from structural healthcare trends, including rising health spending, an aging population and the growing burden of chronic disease. The company reallocates resources to more profitable areas and makes prudent acquisitions. ELV's return on invested capital of 9.36% is higher than the industry average of 5.80%, which indicates that the company is more efficient in generating returns from its capital than the industry. Its consistent dividend payouts and stock repurchases boost shareholders' value. Elevance's dividend yield of 2.33% is higher than the industry average of 1.37%. ELV bought back shares worth $379 million in the second quarter alone. It had a leftover capacity of roughly $8 billion under its share buyback authorization as of June 30, 2025. To Conclude While Elevance's beaten-down valuation and strong long-term industry tailwinds might tempt bargain hunters, the near-term outlook remains clouded by shrinking memberships, rising medical costs, regulatory risks and deteriorating analyst sentiment. With earnings estimates moving sharply lower and the stock currently carrying a Zacks Rank #5 (Strong Sell), investors may want to stay on the sidelines until the company's fundamentals show clearer signs of recovery. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. See our %%CTA_TEXT%% report – free today! 7 Best Stocks for the Next 30 Days Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report UnitedHealth Group Incorporated (UNH): Free Stock Analysis Report Centene Corporation (CNC): Free Stock Analysis Report Elevance Health, Inc. (ELV): Free Stock Analysis Report
Globe and Mail
29 minutes ago
- Globe and Mail
NuScale Power Shares Rise 7% on Narrower Q2 Loss, Revenue Up Y/Y
NuScale Power SMR shares have gained 7.2% since the company reported its second-quarter 2025 results on Aug. 7. The upward momentum can be attributed to NuScale Power's strong year-over-year revenue growth and early NRC approval for its 77 MWe SMR design. In the second quarter of 2025, NuScale Power reported loss per share of 13 cents, which was narrower than the loss of 31 cents reported in the year-ago quarter. The figure missed the Zacks Consensus Estimate by 8.33%. The company reported revenues of $8.1 billion for the quarter, marking a significant increase of 733% from $967 million in the prior-year quarter. However, the figure missed the Zacks Consensus Estimate by 11.15%. The year-over-year increase was driven by the higher fees from engineering, licensing, and pre-commercial operational services for the RoPower project. In the second quarter of 2025, SMR achieved approval for its 77-megawatt power uprate design, solidifying its position as the only SMR technology with two NRC approvals. NuScale Power shares have appreciated 119.5% year to date, outperforming the Zacks Computer & Technology sector's 13.8% return. SMR Q2 Operating Details SMR's second-quarter 2025 gross margin increased to 22.1% from 12.1% in the second quarter of 2024. In the second quarter, operating expenses increased 6.8% year over year to $44.86 million. In the reported quarter, research & development expenses declined 2.7% year over year to $11.8 million. General & administrative expenses increased 33.8% year over year to $22.52 million. Other expenses decreased 19.2% year over year to $10.54 million. The company reported a loss from operations of $43.08 million, up from $41.8 million in the year-ago quarter. SMR's Balance Sheet Details As of June 30, 2025, NuScale Power had cash and cash equivalents and short-term investments of $420.7 million compared with $521.4 million as of March 31, 2025. SMR's Earnings Estimates Show Upward Movement For the third quarter of 2025, the Zacks Consensus Estimate for loss is pegged at 11 cents per share, which has remained unchanged over the past 30 days. SMR reported earnings of 18 cents per share in the year-ago quarter. The Zacks Consensus Estimate for third-quarter 2025 revenues is pegged at $11.10 million, indicating a year-over-year increase of 2,260.64%. Zacks Rank & Stocks to Consider NuScale Power currently carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the broader Zacks Computer and Technology sector are Autodesk ADSK, Applied Materials AMAT, and Cisco Systems CSCO. Each stock carries a Zacks Rank #2 (Buy) at present. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Autodesk is set to report second-quarter fiscal 2026 results on Aug. 28. Autodesk shares have lost 1.6% year to date. Applied Materials is slated to report third-quarter fiscal 2025 results on Aug. 14. Applied Materials Power shares have gained 13.7% year to date. Cisco Systems is set to report fourth-quarter fiscal 2025 results on Aug. 13. Cisco Systems shares have rallied 21.3% year to date. See our %%CTA_TEXT%% report – free today! 7 Best Stocks for the Next 30 Days Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Cisco Systems, Inc. (CSCO): Free Stock Analysis Report Autodesk, Inc. (ADSK): Free Stock Analysis Report Applied Materials, Inc. (AMAT): Free Stock Analysis Report NuScale Power Corporation (SMR): Free Stock Analysis Report
